HuR inhibitors (University of Oklahoma)

N/A

Report date: 2025/01/26 18:04:40
NME

Base Information

Drug NameHuR inhibitors (University of Oklahoma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionELAV-like protein 1 inhibitors
TargetsELAV-like protein 1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oklahoma Health Sciences Center
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oklahoma Health Sciences Center
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A